Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng Kang

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
ACS Nano|January 19, 2021
Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine CandidatesYin-Feng Kang, Cong Sun, Zhen Zhuang, et al.
Cell Reports. Medicine|November 22, 2023
Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infectionJunping Hong, Ling Zhong, Liqin Liu, et al.
Cell Host & Microbe|October 17, 2023
A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBVCong Sun, Yin-Feng Kang, Xin-Yan Fang, et al.
The Journal of Clinical Investigation|November 26, 2024
A large-scale population-based study reveals that gp42-IgG antibody is protective against EBV-associated nasopharyngeal carcinomaXiang-Wei Kong, Guo-Long Bu, Hua Chen, et al.
World Journal of Gastroenterology|June 23, 2017
Ischemic or toxic injury: A challenging diagnosis and treatment of drug-induced stenosis of the sigmoid colonZong-Ming Zhang, Xiang-Chun Lin, Li Ma, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
ACS Nano|January 19, 2021
Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine CandidatesYin-Feng Kang, Cong Sun, Zhen Zhuang, et al.
Cell Reports. Medicine|November 22, 2023
Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infectionJunping Hong, Ling Zhong, Liqin Liu, et al.
Cell Host & Microbe|October 17, 2023
A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBVCong Sun, Yin-Feng Kang, Xin-Yan Fang, et al.
The Journal of Clinical Investigation|November 26, 2024
A large-scale population-based study reveals that gp42-IgG antibody is protective against EBV-associated nasopharyngeal carcinomaXiang-Wei Kong, Guo-Long Bu, Hua Chen, et al.
World Journal of Gastroenterology|June 23, 2017
Ischemic or toxic injury: A challenging diagnosis and treatment of drug-induced stenosis of the sigmoid colonZong-Ming Zhang, Xiang-Chun Lin, Li Ma, et al.
Pageof 18